Yesterday, the Minnesota Department of Health approved adding Alzheimer’s disease as a qualifying condition for medical cannabis, but rejected opioid use disorder, hepatitis C, traumatic brain injury, and insomnia.
Many thanks to Sensible Minnesota and to all the advocates and health professionals who were involved in petitioning to expand the program! Their dedicated work (with an assist from MPP) also resulted in the addition of intractable pain, PTSD, autism, and sleep apnea.
Under state law, Alzheimer’s disease patients will be able to apply for medical cannabis starting next summer.
Last November, the Minnesota Department of Health approved adding autism spectrum disorders and obstructive sleep apnea as qualifying conditions for the state’s medical cannabis program. Under state law, the additions take effect the following summer.
Starting on July 1, 2018, patients with a doctor’s certification and either of those conditions could begin registering for the program. They can start accessing medical cannabis no sooner than August 1. Our allies at Sensible Minnesota offer one-on-one assistance to patients who need help navigating the process. Learn more here.
Congratulations to Sensible Minnesota and to all the advocates and health professionals who were involved in petitioning to expand the program!
Sensible Minnesota is now working on petitions to expand the program to include opioid use disorder, hepatitis C, Alzheimer’s, traumatic brain injury, and insomnia.
If you are a Minnesota medical professional who might be willing to add your voice to the petition, contact Sensible Minnesota at 952-529-4420 or by email.